SlideShare a Scribd company logo
1 of 23
Download to read offline
Comparing the reliability and diagnostic
accuracy of routine NHS laboratories
and a research laboratory in the
Diagnosis of Urinary Tract infection in
Young children (DUTY) study
Kim Harman on behalf of the
DUTY study team
Research aim
Aim
To compare the reliability and diagnostic accuracy of
two different types of laboratory in the urinalysis with
regard to UTI
Background
There is a ‘National standard method’ for urinalysis but it is
unknown how much this is adhered to.
Few studies have compared routine NHS laboratory
reporting of results against a single standardised laboratory.
Evidence for laboratory processes is weak.
Whole study design
• Cross sectional diagnostic accuracy study with prospective
f/u
• ‘Open’ inclusion criteria
– Children <5 years old
– Presenting to primary care with an acute (<28 days) illness
• Constitutionally unwell and / or
• Urinary symptoms, even if clinician ‘knows’ the diagnosis
• Excluded
– Neurogenic bladder
– Antibiotics <7 days
– Trauma as main concern
Data collected
• Data collection
– Baseline demographics, symptoms and signs (n=63) rated
none/mild/moderate or severe
• Urine sample
– Preference clean catch, then Newcastle Nappy pad
– Urine dipstick testing
• Urine sample split and sent to
– Local NHS laboratory for routine microscopy and culture
– More detailed research laboratory (RL) analysis
Methods (1)
Definitions of UTI
• NHS laboratory
– Report of pure/predominant growth of a uropathogen (e.g. e.coli,
proteus, etc) at ≥105 cfu/ml
• Research laboratory
– Growth of ≥105 cfu/ml of a single uropathogen (“pure growth”)
– Or growth of ≥105 of a uropathogen with ≥3 log10 (1000-fold)
difference between growth of this and the next species
(“predominant growth”)
Methods(2)
Association with a priori specified variables clearly
associated with the presence of UTI from the literature
Pain/crying when passing urine
Passing urine more often
Changes in urine appearance
Temperature ≥ 39°C
Dipstick nitrite positive
Dipstick leukocyte positive
(Hay AD, Whiting P, Butler CC. How best to diagnose urinary tract infection
in preschool children in primary care? BMJ 2011; 343:d6316.)
General results
1. 69 Local NHS Labs involved
2. 6,079 Local NHS Laboratory urines
3. 5,107 Research Laboratory urines
4. 4,808 children with predictors from CRF & urine at
both labs
Study participants
Category Age <3 years Age 3-5 years
Gender Male 1439 (49.9%) 919 (47.8%)
Female 1445 (50.1%) 1005 (52.2%)
Age (years) 0 to <1 1016 (35.2%)
1 to <2 942 (32.7%)
2 to <3 926 (32.1%)
3 to <4 1099 (57.1%)
4 to <5 825 (42.9%)
Sample method Clean catch 758 (26.3%) 1861 (96.7%)
Nappy pad 2126 (73.7%) 63 (3.3%)
Urine sample results
Result Age <3 years Age 3-5 years
NHS laboratory Positive 189 (6.6%) 62 (3.2%)
Research
laboratory
Positive 51 (1.8%) 37 (1.9%)
Kappa 95% CI
Both collection methods 0.36 (0.29, 0.43)
Clean catch 0.54 (0.45, 0.63)
Nappy pad 0.20 (0.12, 0.28)
≥ 3 years 0.53 (0.41, 0.65)
Clean catch 0.55 (0.43, 0.67)
Nappy pad N/A
<3 years 0.29 (0.21, 0.36)
Clean catch 0.52 (0.37, 0.67)
Nappy pad 0.20 (0.12, 0.28)
Similar patterns were seen when comparisons were further stratified into age
groups <2 and ≥2 to <3 years. N/A is not available – too few results
Between lab comparisons
Associations with variables
Clean catch Nappy pad
Research laboratory
AUC (95% CI) 0.86 (0.79, 0.92) 0.79 (0.70,0.88)
NHS laboratories
AUC (95% CI) 0.75 (0.69,0.80) 0.65 (0.61,0.70)
00.51
1 0.5 0
Clean catch
UTI + ve in NHS
00.51
1 0.5 0
Nappy pad
00.51
1 0.5 0
UTI +ve in RL
00.51
1 0.5 0
Sensitivity
Specificity
Between lab comparisons
Summary of main results
• There is worse than expected agreement between
the labs and between collection methods
• Associations of microbiological positivity with pre-
specified signs/symptoms were lower for:
– NHS positivity than for research laboratory positivity
– Nappy pad samples than for clean catch samples
Implications - microbiological
NHS labs may wish to adopt the methods of the research
laboratory.
Implications – clinical
More effort should be spent on obtaining higher
quality (clean catch) samples, even in the very young
Implications - research
Leading hypothesis is that for nappy pad samples
the NHS labs overdiagnose UTI because of failure to
identify contamination
NIHR disclaimer
This project was funded by the NIHR Health Technology
Assessment Programme (project number 08/66/01) and will
be published in full as a Health Technology Assessment.
The views and opinions expressed therein are those of the
authors and do not necessarily reflect those of the HTA
programme, NIHR, NHS or the Department of Health.
Thank you team
Investigators
Alastair Hay (co-CI) Study Managers
Chris Butler (co-CI) Jonathan Sterne Harriet Downing
Peter Brindle Judith van der Voort Marilyn Peters
Brendan Delaney Penny Whiting Kate Rumsby
Jan Dudley Data Manager Emma Thomas-Jones
Margaret Fletcher Cathy Lisles Cherry-Ann Waldron
Will Hollingworth Database manager Statisticians
Kerenza Hood Stevo Durbaba Kate Birnie
Robin Howe Microbiologist Michael Lawton
Paul Little Mandy Wootton Tim Pickles
Alasdair MacGowan Health economist DUTY nurses / CSOs
Kathy O’Brien John Busby
Primary care clinicians
Children & their families
Associations in Research Lab
Central laboratory
Clean catch Nappy pad
OR (95% CI) p OR (95% CI) p
Pain/crying passing urine 6.0 (3.0, 11.8) <0.001 1.4 (0.3, 7.0) 0.716
Passing urine more often 0.8 (0.4, 1.7) 0.543 1.2 (0.3, 4.4) 0.839
Change in urine appearance 3.1 (1.6, 6.1) 0.001 3.1 (1.2, 7.9) 0.019
Temperature ≥39°C 1.7 (0.6, 5.1) 0.333 1.1 (0.1, 8.8) 0.930
Dipstick: nitrite +ve 11.2 (5.4, 23.1) <0.001 5.2 (2.4, 11.3) <0.001
Dipstick: leukocyte +ve 5.3 (2.8, 10.0) <0.001 4.1 (1.9, 8.9) <0.001
AUC (95% CI) 0.86 (0.79 0.92) 0.79 (0.70, 0.88)
Associations in NHS labs
NHS laboratory
Clean catch Nappy pad
OR (95% CI) p OR (95% CI) p
Pain/crying passing urine 2.9 (1.6, 5.1) <0.001 1.1 (0.4, 3.1) 0.838
Passing urine more often 0.6 (0.3, 1.1) 0.073 0.7 (0.3, 1.5) 0.370
Change in urine appearance 3.0 (1.8, 4.9) <0.001 2.1 (1.3, 3.5) 0.005
Temperature ≥39°C 1.7 (0.8, 3.8) 0.157 0.7 (0.2, 2.2) 0.526
Dipstick: nitrite +ve 7.6 (4.1, 14.1) <0.001 2.0 (1.4, 2.9) 0.001
Dipstick: leukocyte +ve 3.1 (1.9, 5.1) <0.001 3.1 (2.1, 4.4) <0.001
AUC (95% CI) 0.75 (0.69, 0.80) 0.65 (0.61, 0.70)
0.1.2.3.4
s.e.ofkappa
-.5 0 .5 1
kappa
Funnel plot 95% confidence limits

More Related Content

Viewers also liked

5 motivi per cui la Grande Azienda è Bisanzio
5 motivi per cui la Grande Azienda è Bisanzio5 motivi per cui la Grande Azienda è Bisanzio
5 motivi per cui la Grande Azienda è Bisanziobiljaic
 
ฐานข้อมูล DOA
ฐานข้อมูล DOAฐานข้อมูล DOA
ฐานข้อมูล DOApartong
 
Networking Ninja: alcuni consigli per sfruttare meglio gli eventi
Networking Ninja: alcuni consigli per sfruttare meglio gli eventiNetworking Ninja: alcuni consigli per sfruttare meglio gli eventi
Networking Ninja: alcuni consigli per sfruttare meglio gli eventiGiorgio Minguzzi
 
Nns Mesra Trading (Assignment : Identiti Rekabentuk Korporat)
Nns Mesra Trading (Assignment : Identiti Rekabentuk Korporat)Nns Mesra Trading (Assignment : Identiti Rekabentuk Korporat)
Nns Mesra Trading (Assignment : Identiti Rekabentuk Korporat)IzzuwanIsmail
 
Political & macro enviroment impact on coca cola
Political & macro enviroment impact on coca colaPolitical & macro enviroment impact on coca cola
Political & macro enviroment impact on coca colaManjula Weerakoon
 
4 am kal_2015
4 am kal_20154 am kal_2015
4 am kal_2015klas4
 
LECTURE 9.ppt SOLID WASTE MANAGEMENT
LECTURE 9.ppt SOLID WASTE MANAGEMENTLECTURE 9.ppt SOLID WASTE MANAGEMENT
LECTURE 9.ppt SOLID WASTE MANAGEMENTSEURI KILAKOI
 
Red4348 critical assignment 1
Red4348 critical assignment 1Red4348 critical assignment 1
Red4348 critical assignment 1egurklis
 
Bị béo phì tiềm ẩn, béo bụng gây các bệnh mạn tính nguy hiểm
Bị béo phì tiềm ẩn, béo bụng gây các bệnh mạn tính nguy hiểmBị béo phì tiềm ẩn, béo bụng gây các bệnh mạn tính nguy hiểm
Bị béo phì tiềm ẩn, béo bụng gây các bệnh mạn tính nguy hiểmalva148
 
Что такое НЛТР
Что такое НЛТРЧто такое НЛТР
Что такое НЛТРNLTR
 

Viewers also liked (19)

5 motivi per cui la Grande Azienda è Bisanzio
5 motivi per cui la Grande Azienda è Bisanzio5 motivi per cui la Grande Azienda è Bisanzio
5 motivi per cui la Grande Azienda è Bisanzio
 
Redsky
RedskyRedsky
Redsky
 
Genkiphonicsposters
GenkiphonicspostersGenkiphonicsposters
Genkiphonicsposters
 
Fire Toad Logo
Fire Toad LogoFire Toad Logo
Fire Toad Logo
 
Th3 N!N!@S Gr0on3
Th3 N!N!@S Gr0on3Th3 N!N!@S Gr0on3
Th3 N!N!@S Gr0on3
 
ABHISHEK TIWARI
ABHISHEK TIWARIABHISHEK TIWARI
ABHISHEK TIWARI
 
ฐานข้อมูล DOA
ฐานข้อมูล DOAฐานข้อมูล DOA
ฐานข้อมูล DOA
 
Networking Ninja: alcuni consigli per sfruttare meglio gli eventi
Networking Ninja: alcuni consigli per sfruttare meglio gli eventiNetworking Ninja: alcuni consigli per sfruttare meglio gli eventi
Networking Ninja: alcuni consigli per sfruttare meglio gli eventi
 
Mercredis Patrimoine : Les fleurs
Mercredis Patrimoine : Les fleursMercredis Patrimoine : Les fleurs
Mercredis Patrimoine : Les fleurs
 
Nns Mesra Trading (Assignment : Identiti Rekabentuk Korporat)
Nns Mesra Trading (Assignment : Identiti Rekabentuk Korporat)Nns Mesra Trading (Assignment : Identiti Rekabentuk Korporat)
Nns Mesra Trading (Assignment : Identiti Rekabentuk Korporat)
 
Political & macro enviroment impact on coca cola
Political & macro enviroment impact on coca colaPolitical & macro enviroment impact on coca cola
Political & macro enviroment impact on coca cola
 
Anatomi dan fisiologi
Anatomi dan fisiologiAnatomi dan fisiologi
Anatomi dan fisiologi
 
4 am kal_2015
4 am kal_20154 am kal_2015
4 am kal_2015
 
LECTURE 9.ppt SOLID WASTE MANAGEMENT
LECTURE 9.ppt SOLID WASTE MANAGEMENTLECTURE 9.ppt SOLID WASTE MANAGEMENT
LECTURE 9.ppt SOLID WASTE MANAGEMENT
 
Red4348 critical assignment 1
Red4348 critical assignment 1Red4348 critical assignment 1
Red4348 critical assignment 1
 
all criticism
all criticismall criticism
all criticism
 
ICC Talks Nigeria
ICC Talks NigeriaICC Talks Nigeria
ICC Talks Nigeria
 
Bị béo phì tiềm ẩn, béo bụng gây các bệnh mạn tính nguy hiểm
Bị béo phì tiềm ẩn, béo bụng gây các bệnh mạn tính nguy hiểmBị béo phì tiềm ẩn, béo bụng gây các bệnh mạn tính nguy hiểm
Bị béo phì tiềm ẩn, béo bụng gây các bệnh mạn tính nguy hiểm
 
Что такое НЛТР
Что такое НЛТРЧто такое НЛТР
Что такое НЛТР
 

Similar to Comparing the reliability and diagnostic accuracy of routine NHS laboratories and a research laboratory in the diagnosis of urinary tract infection

Antiretroviral intensification to prevent intrapartum HIV transmission in lat...
Antiretroviral intensification to prevent intrapartum HIV transmission in lat...Antiretroviral intensification to prevent intrapartum HIV transmission in lat...
Antiretroviral intensification to prevent intrapartum HIV transmission in lat...Илья Антипин
 
3 of 4: Reducing Neonatal Mortality - Prevention, Early Detection and Treatme...
3 of 4: Reducing Neonatal Mortality - Prevention, Early Detection and Treatme...3 of 4: Reducing Neonatal Mortality - Prevention, Early Detection and Treatme...
3 of 4: Reducing Neonatal Mortality - Prevention, Early Detection and Treatme...JSI
 
Maximizing Outcomes in Assisted Reproductive Technology by Individualization
Maximizing Outcomes in Assisted Reproductive Technology by IndividualizationMaximizing Outcomes in Assisted Reproductive Technology by Individualization
Maximizing Outcomes in Assisted Reproductive Technology by IndividualizationSandro Esteves
 
Screening for critical_congenital_heart_defects_with_pulse_oximetry_uk_perspe...
Screening for critical_congenital_heart_defects_with_pulse_oximetry_uk_perspe...Screening for critical_congenital_heart_defects_with_pulse_oximetry_uk_perspe...
Screening for critical_congenital_heart_defects_with_pulse_oximetry_uk_perspe...eram sid
 
複製 Human embryo transfer11
複製  Human   embryo   transfer11複製  Human   embryo   transfer11
複製 Human embryo transfer11t7260678
 
Human embryo transfer11
Human   embryo   transfer11Human   embryo   transfer11
Human embryo transfer11t7260678
 
Assay Standardisation - how this leads to improved patient results
Assay Standardisation - how this leads to improved patient resultsAssay Standardisation - how this leads to improved patient results
Assay Standardisation - how this leads to improved patient resultsWalt Whitman
 
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...Institut national du cancer
 
10 settles pelvic floor disorders
10 settles pelvic floor disorders10 settles pelvic floor disorders
10 settles pelvic floor disordersangel4567
 
GEMC: Non-Traumatic Abdominal Pain/Abdominal Emergencies: Resident Training
GEMC: Non-Traumatic Abdominal Pain/Abdominal Emergencies: Resident TrainingGEMC: Non-Traumatic Abdominal Pain/Abdominal Emergencies: Resident Training
GEMC: Non-Traumatic Abdominal Pain/Abdominal Emergencies: Resident TrainingOpen.Michigan
 
GEMC - Non-Traumatic Abdominal Pain/Abdominal Emergencies- Resident Training
GEMC - Non-Traumatic Abdominal Pain/Abdominal Emergencies- Resident TrainingGEMC - Non-Traumatic Abdominal Pain/Abdominal Emergencies- Resident Training
GEMC - Non-Traumatic Abdominal Pain/Abdominal Emergencies- Resident TrainingOpen.Michigan
 
Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...
Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...
Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...Sandro Esteves
 

Similar to Comparing the reliability and diagnostic accuracy of routine NHS laboratories and a research laboratory in the diagnosis of urinary tract infection (20)

Supplementation Trial of KOKO Plus Among HIV Exposed Children in Accra
Supplementation Trial of KOKO Plus Among HIV Exposed Children in AccraSupplementation Trial of KOKO Plus Among HIV Exposed Children in Accra
Supplementation Trial of KOKO Plus Among HIV Exposed Children in Accra
 
Antiretroviral intensification to prevent intrapartum HIV transmission in lat...
Antiretroviral intensification to prevent intrapartum HIV transmission in lat...Antiretroviral intensification to prevent intrapartum HIV transmission in lat...
Antiretroviral intensification to prevent intrapartum HIV transmission in lat...
 
Asbo
AsboAsbo
Asbo
 
Cochrane
CochraneCochrane
Cochrane
 
Op 9-1
Op 9-1Op 9-1
Op 9-1
 
Clinical audit OBST & GYNAE.pptx
Clinical audit OBST & GYNAE.pptxClinical audit OBST & GYNAE.pptx
Clinical audit OBST & GYNAE.pptx
 
3 of 4: Reducing Neonatal Mortality - Prevention, Early Detection and Treatme...
3 of 4: Reducing Neonatal Mortality - Prevention, Early Detection and Treatme...3 of 4: Reducing Neonatal Mortality - Prevention, Early Detection and Treatme...
3 of 4: Reducing Neonatal Mortality - Prevention, Early Detection and Treatme...
 
Maximizing Outcomes in Assisted Reproductive Technology by Individualization
Maximizing Outcomes in Assisted Reproductive Technology by IndividualizationMaximizing Outcomes in Assisted Reproductive Technology by Individualization
Maximizing Outcomes in Assisted Reproductive Technology by Individualization
 
Screening for critical_congenital_heart_defects_with_pulse_oximetry_uk_perspe...
Screening for critical_congenital_heart_defects_with_pulse_oximetry_uk_perspe...Screening for critical_congenital_heart_defects_with_pulse_oximetry_uk_perspe...
Screening for critical_congenital_heart_defects_with_pulse_oximetry_uk_perspe...
 
複製 Human embryo transfer11
複製  Human   embryo   transfer11複製  Human   embryo   transfer11
複製 Human embryo transfer11
 
Human embryo transfer11
Human   embryo   transfer11Human   embryo   transfer11
Human embryo transfer11
 
Assay Standardisation - how this leads to improved patient results
Assay Standardisation - how this leads to improved patient resultsAssay Standardisation - how this leads to improved patient results
Assay Standardisation - how this leads to improved patient results
 
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...
Colloque RI 2014 : Intervention de Michael B. POTTER, MD, (University of Cali...
 
10 settles pelvic floor disorders
10 settles pelvic floor disorders10 settles pelvic floor disorders
10 settles pelvic floor disorders
 
GEMC: Non-Traumatic Abdominal Pain/Abdominal Emergencies: Resident Training
GEMC: Non-Traumatic Abdominal Pain/Abdominal Emergencies: Resident TrainingGEMC: Non-Traumatic Abdominal Pain/Abdominal Emergencies: Resident Training
GEMC: Non-Traumatic Abdominal Pain/Abdominal Emergencies: Resident Training
 
GEMC - Non-Traumatic Abdominal Pain/Abdominal Emergencies- Resident Training
GEMC - Non-Traumatic Abdominal Pain/Abdominal Emergencies- Resident TrainingGEMC - Non-Traumatic Abdominal Pain/Abdominal Emergencies- Resident Training
GEMC - Non-Traumatic Abdominal Pain/Abdominal Emergencies- Resident Training
 
Cholestasis 8
Cholestasis 8Cholestasis 8
Cholestasis 8
 
RH_pap_test.ppt
RH_pap_test.pptRH_pap_test.ppt
RH_pap_test.ppt
 
Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...
Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...
Embryo Transfer Technologies and Luteal Phase Support to Maximize Pregnancy R...
 
Pediatric Uti
Pediatric UtiPediatric Uti
Pediatric Uti
 

Comparing the reliability and diagnostic accuracy of routine NHS laboratories and a research laboratory in the diagnosis of urinary tract infection

  • 1. Comparing the reliability and diagnostic accuracy of routine NHS laboratories and a research laboratory in the Diagnosis of Urinary Tract infection in Young children (DUTY) study Kim Harman on behalf of the DUTY study team
  • 2. Research aim Aim To compare the reliability and diagnostic accuracy of two different types of laboratory in the urinalysis with regard to UTI
  • 3. Background There is a ‘National standard method’ for urinalysis but it is unknown how much this is adhered to. Few studies have compared routine NHS laboratory reporting of results against a single standardised laboratory. Evidence for laboratory processes is weak.
  • 4.
  • 5. Whole study design • Cross sectional diagnostic accuracy study with prospective f/u • ‘Open’ inclusion criteria – Children <5 years old – Presenting to primary care with an acute (<28 days) illness • Constitutionally unwell and / or • Urinary symptoms, even if clinician ‘knows’ the diagnosis • Excluded – Neurogenic bladder – Antibiotics <7 days – Trauma as main concern
  • 6. Data collected • Data collection – Baseline demographics, symptoms and signs (n=63) rated none/mild/moderate or severe • Urine sample – Preference clean catch, then Newcastle Nappy pad – Urine dipstick testing • Urine sample split and sent to – Local NHS laboratory for routine microscopy and culture – More detailed research laboratory (RL) analysis
  • 7. Methods (1) Definitions of UTI • NHS laboratory – Report of pure/predominant growth of a uropathogen (e.g. e.coli, proteus, etc) at ≥105 cfu/ml • Research laboratory – Growth of ≥105 cfu/ml of a single uropathogen (“pure growth”) – Or growth of ≥105 of a uropathogen with ≥3 log10 (1000-fold) difference between growth of this and the next species (“predominant growth”)
  • 8. Methods(2) Association with a priori specified variables clearly associated with the presence of UTI from the literature Pain/crying when passing urine Passing urine more often Changes in urine appearance Temperature ≥ 39°C Dipstick nitrite positive Dipstick leukocyte positive (Hay AD, Whiting P, Butler CC. How best to diagnose urinary tract infection in preschool children in primary care? BMJ 2011; 343:d6316.)
  • 9. General results 1. 69 Local NHS Labs involved 2. 6,079 Local NHS Laboratory urines 3. 5,107 Research Laboratory urines 4. 4,808 children with predictors from CRF & urine at both labs
  • 10. Study participants Category Age <3 years Age 3-5 years Gender Male 1439 (49.9%) 919 (47.8%) Female 1445 (50.1%) 1005 (52.2%) Age (years) 0 to <1 1016 (35.2%) 1 to <2 942 (32.7%) 2 to <3 926 (32.1%) 3 to <4 1099 (57.1%) 4 to <5 825 (42.9%) Sample method Clean catch 758 (26.3%) 1861 (96.7%) Nappy pad 2126 (73.7%) 63 (3.3%)
  • 11. Urine sample results Result Age <3 years Age 3-5 years NHS laboratory Positive 189 (6.6%) 62 (3.2%) Research laboratory Positive 51 (1.8%) 37 (1.9%)
  • 12. Kappa 95% CI Both collection methods 0.36 (0.29, 0.43) Clean catch 0.54 (0.45, 0.63) Nappy pad 0.20 (0.12, 0.28) ≥ 3 years 0.53 (0.41, 0.65) Clean catch 0.55 (0.43, 0.67) Nappy pad N/A <3 years 0.29 (0.21, 0.36) Clean catch 0.52 (0.37, 0.67) Nappy pad 0.20 (0.12, 0.28) Similar patterns were seen when comparisons were further stratified into age groups <2 and ≥2 to <3 years. N/A is not available – too few results Between lab comparisons
  • 13. Associations with variables Clean catch Nappy pad Research laboratory AUC (95% CI) 0.86 (0.79, 0.92) 0.79 (0.70,0.88) NHS laboratories AUC (95% CI) 0.75 (0.69,0.80) 0.65 (0.61,0.70)
  • 14. 00.51 1 0.5 0 Clean catch UTI + ve in NHS 00.51 1 0.5 0 Nappy pad 00.51 1 0.5 0 UTI +ve in RL 00.51 1 0.5 0 Sensitivity Specificity Between lab comparisons
  • 15. Summary of main results • There is worse than expected agreement between the labs and between collection methods • Associations of microbiological positivity with pre- specified signs/symptoms were lower for: – NHS positivity than for research laboratory positivity – Nappy pad samples than for clean catch samples
  • 16. Implications - microbiological NHS labs may wish to adopt the methods of the research laboratory.
  • 17. Implications – clinical More effort should be spent on obtaining higher quality (clean catch) samples, even in the very young
  • 18. Implications - research Leading hypothesis is that for nappy pad samples the NHS labs overdiagnose UTI because of failure to identify contamination
  • 19. NIHR disclaimer This project was funded by the NIHR Health Technology Assessment Programme (project number 08/66/01) and will be published in full as a Health Technology Assessment. The views and opinions expressed therein are those of the authors and do not necessarily reflect those of the HTA programme, NIHR, NHS or the Department of Health.
  • 20. Thank you team Investigators Alastair Hay (co-CI) Study Managers Chris Butler (co-CI) Jonathan Sterne Harriet Downing Peter Brindle Judith van der Voort Marilyn Peters Brendan Delaney Penny Whiting Kate Rumsby Jan Dudley Data Manager Emma Thomas-Jones Margaret Fletcher Cathy Lisles Cherry-Ann Waldron Will Hollingworth Database manager Statisticians Kerenza Hood Stevo Durbaba Kate Birnie Robin Howe Microbiologist Michael Lawton Paul Little Mandy Wootton Tim Pickles Alasdair MacGowan Health economist DUTY nurses / CSOs Kathy O’Brien John Busby Primary care clinicians Children & their families
  • 21. Associations in Research Lab Central laboratory Clean catch Nappy pad OR (95% CI) p OR (95% CI) p Pain/crying passing urine 6.0 (3.0, 11.8) <0.001 1.4 (0.3, 7.0) 0.716 Passing urine more often 0.8 (0.4, 1.7) 0.543 1.2 (0.3, 4.4) 0.839 Change in urine appearance 3.1 (1.6, 6.1) 0.001 3.1 (1.2, 7.9) 0.019 Temperature ≥39°C 1.7 (0.6, 5.1) 0.333 1.1 (0.1, 8.8) 0.930 Dipstick: nitrite +ve 11.2 (5.4, 23.1) <0.001 5.2 (2.4, 11.3) <0.001 Dipstick: leukocyte +ve 5.3 (2.8, 10.0) <0.001 4.1 (1.9, 8.9) <0.001 AUC (95% CI) 0.86 (0.79 0.92) 0.79 (0.70, 0.88)
  • 22. Associations in NHS labs NHS laboratory Clean catch Nappy pad OR (95% CI) p OR (95% CI) p Pain/crying passing urine 2.9 (1.6, 5.1) <0.001 1.1 (0.4, 3.1) 0.838 Passing urine more often 0.6 (0.3, 1.1) 0.073 0.7 (0.3, 1.5) 0.370 Change in urine appearance 3.0 (1.8, 4.9) <0.001 2.1 (1.3, 3.5) 0.005 Temperature ≥39°C 1.7 (0.8, 3.8) 0.157 0.7 (0.2, 2.2) 0.526 Dipstick: nitrite +ve 7.6 (4.1, 14.1) <0.001 2.0 (1.4, 2.9) 0.001 Dipstick: leukocyte +ve 3.1 (1.9, 5.1) <0.001 3.1 (2.1, 4.4) <0.001 AUC (95% CI) 0.75 (0.69, 0.80) 0.65 (0.61, 0.70)
  • 23. 0.1.2.3.4 s.e.ofkappa -.5 0 .5 1 kappa Funnel plot 95% confidence limits